Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 11
Submit an article Journal homepage
256
Views
2
CrossRef citations to date
0
Altmetric
Reviews

What constitutes meaningful improvement in myelodysplastic syndromes?

Namrata S. ChandhokDivision of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA
&
Mikkael A. SekeresDivision of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USACorrespondence[email protected]
Pages 2528-2535 | Received 07 Apr 2022, Accepted 23 May 2022, Published online: 14 Jun 2022

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Sangeetha Venugopal & Mikkael A. Sekeres. (2023) Raising the bar for lower-risk myelodysplastic syndromes. Leukemia & Lymphoma 64:6, pages 1082-1091.
Read now

Articles from other publishers (1)

Lisa Pleyer, Marc Vaisband, Manuel Drost, Michael Pfeilstöcker, Reinhard Stauder, Sonja Heibl, Heinz Sill, Michael Girschikofsky, Margarete Stampfl‐Mattersberger, Angelika Pichler, Bernd Hartmann, Andreas Petzer, Martin Schreder, Clemens A. Schmitt, Sonia Vallet, Thomas Melchardt, Armin Zebisch, Petra Pichler, Nadja Zaborsky, Sigrid Machherndl‐Spandl, Dominik Wolf, Felix Keil, Jan Hasenauer, Julian Larcher‐Senn & Richard Greil. (2023) Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine—A prospective cohort study by the AGMT . American Journal of Hematology.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.